GYROSCOPE THERAPEUTICS
Gyroscope is a clinical-stage gene therapy company focused on developing therapies and treating diseases of the eye. The company explores the convergence of advancements made in the understanding of the complement system’s impact on eye disease, the genetic basis of Age-related Macular Degeneration (AMD), and gene therapy as a mode of treatment delivery. Its lead investigational gene therapy, GT005, is a one-time therapy delivered under the retina. GT005 is designed to restore balance to an o... veractive complement system by increasing the production of the Complement Factor I protein. GT005 is currently being evaluated in a Phase I/II clinical trial called FOCUS and Phase II clinical trials called EXPLORE and HORIZON. Andrew Lotery, David Kavanagh, and Peter Lachmann co-founded Gyroscope Therapeutics in Stevenage, Herefordshire in 2016.
GYROSCOPE THERAPEUTICS
Industry:
Biotechnology Genetics Health Care Therapeutics
Founded:
2016-01-01
Address:
Stevenage, Herefordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.gyroscopetx.com
Total Employee:
101+
Status:
Active
Contact:
+44 (0)1438 906770
Email Addresses:
[email protected]
Total Funding:
269.52 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Harpoon Therapeutics
Harpoon Therapeutics is a clinical-stage immunotherapy company developing novel T cell engagers (TriTACs) for the treatment of cancer.
NorthSea Therapeutics
NorthSea Therapeutics is a clinical-stage biotech company developing first-in class, oral, structurally-engineered lipid therapeutics.
Regulus Therapeutics
Regulus Therapeutics is a clinical stage biopharmaceutical company focused on the development and discovery of microRNA therapeutics.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-04-11 | Orbit Biomedical | Orbit Biomedical acquired by Gyroscope Therapeutics | N/A |
Investors List
Sanofi
Sanofi investment in Corporate Round - Gyroscope Therapeutics
Syncona Partners LLP
Syncona Partners LLP investment in Series C - Gyroscope Therapeutics
Cambridge Innovation Capital
Cambridge Innovation Capital investment in Series C - Gyroscope Therapeutics
Sofinnova Investments
Sofinnova Investments investment in Series C - Gyroscope Therapeutics
Tetragon Financial Group Limited
Tetragon Financial Group Limited investment in Series C - Gyroscope Therapeutics
T. Rowe Price
T. Rowe Price investment in Series C - Gyroscope Therapeutics
Forbion Capital Partners
Forbion Capital Partners investment in Series C - Gyroscope Therapeutics
Fosun Pharma
Fosun Pharma investment in Series C - Gyroscope Therapeutics
Cambridge Innovation Capital
Cambridge Innovation Capital investment in Series B - Gyroscope Therapeutics
Syncona Partners LLP
Syncona Partners LLP investment in Series B - Gyroscope Therapeutics
Official Site Inspections
http://www.gyroscopetx.com Semrush global rank: 3.26 M Semrush visits lastest month: 5.05 K
- Host name: 104.18.27.220
- IP address: 104.18.27.220
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Gyroscope Therapeutics"
Gyroscope Therapeutics - Crunchbase Company Profile & Funding
Gyroscope is a clinical-stage gene therapy company focused on developing therapies and treating diseases of the eye. The company explores the convergence of advancements made in the …See details»
Novartis to acquire Gyroscope Therapeutics, adding a one-time …
Dec 22, 2021 Patient organization funding Payments to healthcare professionals Public policy A living wage A safe workplace Animal research Environmental, social and governance. Learn …See details»
Novartis to acquire Gyroscope Therapeutics, adding a
Dec 22, 2021 Amy Wolf Novartis External Communications +41 79 576 0723 (mobile) [email protected] Julie Masow Novartis US External Communications +1 862 579 8456See details»
Gyroscope Therapeutics - Overview, News & Similar companies
View Gyroscope Therapeutics (www.gyroscopetx.com) location in Hertfordshire, United Kingdom , revenue, industry and description. Find related and similar companies as well as employees …See details»
Gyroscope Therapeutics Announces $148 Million Raised in Series …
Mar 26, 2021 For more information visit: www.gyroscopetx.com and follow us on Twitter (@GyroscopeTx) and on LinkedIn. 1 National Eye Institute. Age-Related Macular Degeneration.See details»
Gyroscope Therapeutics to be Acquired for up to $1.5 Billion
LONDON – 22 December 2021 – Gyroscope Therapeutics Holdings plc (“Gyroscope”), a clinical-stage gene therapy company focused on diseases of the eye, today announced an agreement …See details»
Gyroscope Announces Appointment of Leaders in Retinal Disease …
Apr 8, 2020 Full biographies for members of the Gyroscope Advisory Boards are available at www.gyroscopetx.com. About Gyroscope Therapeutics: Vision for Life Gyroscope …See details»
Gyroscope Therapeutics merges with Orbit Biomedical creating a …
Apr 12, 2019 Gyroscope is a private company headquartered in London, UK and is supported by experts in complement biology, AMD and gene therapy. Investors include Syncona Ltd., …See details»
Gyroscope Therapeutics Announces Sanofi Investment of Up to …
Nov 8, 2021 Charlotte Arnold VP, Corporate Affairs Gyroscope Therapeutics [email protected] [email protected] Release Summary Gyroscope Therapeutics …See details»
Gyroscope Therapeutics acquires Orbit Biomedical - 2019-04-11 ...
Acquiring Organization: Gyroscope Therapeutics Gyroscope Therapeutics is a clinical-stage gene therapy company focused on developing therapies and treating diseases of the eye. ...See details»
Gyroscope Therapeutics Announces Appointments of Industry
Headquartered in London with locations in Philadelphia and San Francisco, our mission is to preserve sight and fight the devastating impact of blindness. For more information visit: …See details»
Gyroscope Therapeutics Announces Sanofi Investment of up to …
LONDON – 8 November 2021 – Gyroscope Therapeutics Holdings plc (Gyroscope), a clinical-stage gene therapy company focused on diseases of the eye, today announced that Sanofi, a …See details»
Gyroscope Therapeutics Announces Sanofi Investment of up to …
Aug 11, 2021 Investment Further Validates Potential of Investigational Gene Therapy GT005 in Geographic Atrophy and Supports Ongoing Phase II Development ProgrammeSee details»
Gyroscope Therapeutics Announces Launch of Initial Public Offering
May 3, 2021 Charlotte Arnold VP, Corporate Affairs Gyroscope Therapeutics [email protected] [email protected] Release Summary Gyroscope Therapeutics …See details»
Gyroscope Therapeutics Announces Presentation of ... - Business …
Sep 30, 2021 Gyroscope Therapeutics Announces Presentation of Positive Interim Phase I/II Data for Investigational Gene Therapy GT005 at Retina Society Annual Scientific MeetingSee details»
Gyroscope Therapeutics Presents Positive Interim Phase 1/2
Sep 30, 2021 Gyroscope Therapeutics announced positive interim data from the ongoing open-label phase 1/2 FOCUS clinical trial of its investigational one-time gene therapy, GT005, in …See details»
Gyroscope Therapeutics Announces Appointment of Tony Adamis …
Jul 12, 2021 Gyroscope Therapeutics Holdings plc, a clinical-stage gene therapy company focused on diseases of the eye, today announced the appointment of biotech industry veteran …See details»
Gyroscope Therapeutics Announces Positive Interim Data from …
Feb 12, 2021 For more information visit: www.gyroscopetx.com and follow us on Twitter (@GyroscopeTx) and on LinkedIn. 1 National Eye Institute. Age-Related Macular Degeneration.See details»
Gene targeting as a therapeutic avenue in diseases mediated by …
Published February 12, 2021, on www.gyroscopetx.com). Furthermore, target engagement and regulation of the amplification loop were demonstrated by a 46% reduction in Ba levels in …See details»
Gyroscope Therapeutics and the University of Pennsylvania …
Dec 18, 2020 For more information visit: www.gyroscopetx.com and follow us on Twitter (@GyroscopeTx) and on LinkedIn. 1 Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng …See details»